| Amgros 2027 1.615.b | Pfizer ApS, Desitin Pharma A/S, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Abacus Medicine A/S, Abcur AB, +4 | 67,3 mio. kr. (samlet) | 30.10.2026 |
| Amgros 2027 1.602.a | Abcur AB, FrostPharma AB, Baxter A/S, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Aguettant Nordic ApS | 73 mio. kr. (samlet) | 29.10.2026 |
| Amgros 2027 2.690.b | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Orifarm Generics A/S, STADA Nordic ApS, Viatris ApS, +7 | 102,2 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 1.605.a | Nordic Prime ApS, Chiesi Pharma AB, McNeil Denmark ApS, Sandoz A/S, Camurus AB | 41 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 2.290.b | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Sandoz A/S, +7 | 46,2 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 1.604.a | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Teva Denmark A/S, +5 | 284,6 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 2.1390.b | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, +2 | 59,2 mio. kr. (samlet) | 26.10.2026 |
| Amgros 2027 1.1070.a | Amgen Filial Af Amgen Ab Sverige | 259 mio. kr. | 26.10.2026 |
| Amgros 2027 1.1076.a | Sanofi A/S | 119 mio. kr. | 26.10.2026 |
| Amgros 2027 1.1206.a | Øresund Pharma ApS, Aguettant Nordic ApS, Takeda Pharma A/S, Viatris ApS, Abacus Medicine A/S, GE Healthcare A/S, +1 | 240 mio. kr. (samlet) | 26.10.2026 |
| Amgros 2027 2.691.b | Teva Denmark A/S, Krka Sverige AB, Orifarm Generics A/S, Macure Pharma ApS, Takeda Pharma A/S, Strides Nordic ApS, +1 | 48,4 mio. kr. (samlet) | 26.10.2026 |
| Amgros 2027 2.1304.a | B. Braun Medical A/S | 35,3 mio. kr. | 23.10.2026 |
| Amgros 2027 1.618.b | Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Takeda Pharma A/S | 32,2 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 1.619.b | B. Braun Medical A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige | 17,6 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 1.606.b | Abcur AB, Orifarm A/S, Abacus Medicine A/S | 101 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 1.603.a | G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Mundipharma A/S, Abcur AB, Hameln Pharma ApS, Jazz Pharmaceuticals Denmark ApS | 148,2 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 2.1303.b | 2care4 Generics ApS, EQL Pharma AB, Macure Pharma ApS, Nordic Prime ApS | 5,7 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 1.1202.a | Macure Pharma ApS, B. Braun Medical A/S, Orifarm Generics A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Aguettant Nordic ApS, Orifarm A/S, +3 | 381,7 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 1.12.a | Aguettant Nordic ApS, Aspen Pharma Ireland Limited | 10,2 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 2.1305.a | B. Braun Medical A/S | 10 mio. kr. | 23.10.2026 |
| Amgros 2027 1.1580.a | GlaxoSmithKline Pharma A/S, AstraZeneca A/S | 169,4 mio. kr. (samlet) | 22.10.2026 |
| Amgros 2027 1.1476.a | GlaxoSmithKline Pharma A/S | 104 mio. kr. | 22.10.2026 |
| Amgros 2027 1.601.a | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS | 75,2 mio. kr. (samlet) | 22.10.2026 |
| Amgros 2027 1.355.a | Pfizer ApS | 32,5 mio. kr. | 22.10.2026 |
| Amgros 2027 2.214.b | Teva Denmark A/S | 4,8 mio. kr. | 22.10.2026 |
| Amgros 2027 1.1207.a | Vingmed A/S, GE Healthcare A/S, Bracco Imaging Scandinavia AB, Bayer A/S | 182,8 mio. kr. (samlet) | 22.10.2026 |
| Amgros 2027 2.1201.a | Paranova Danmark ApS, Orifarm Generics A/S, Pfizer ApS, Gedeon Richter Plc, Orifarm A/S, XGX Pharma ApS, +2 | 128,2 mio. kr. (samlet) | 22.10.2026 |
| Amgros 2027 1.359.a | GlaxoSmithKline Pharma A/S | 143 mio. kr. | 22.10.2026 |
| Amgros 2027 1.1179.a | Stemline Therapeutics B.V. | 32,6 mio. kr. | 22.10.2026 |
| Amgros 2027 1.701.a | Macure Pharma ApS, B. Braun Medical A/S, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, +9 | 899,2 mio. kr. (samlet) | 19.10.2026 |
| Amgros 2027 2.3.b | Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Macure Pharma ApS, Accord Healthcare AB, FrostPharma AB, Zentiva Denmark ApS, Sun Pharmaceuticals Germany GmbH, +10 | 690,9 mio. kr. (samlet) | 19.10.2026 |
| Amgros 2027 1.204.a | Vifor Pharma Nordiska AB, Viatris ApS, Pharmacosmos A/S | 335 mio. kr. (samlet) | 16.10.2026 |
| Amgros 2027 1.1204.a | GE Healthcare A/S, Bracco Imaging Scandinavia AB | 470,9 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.203.b | Pfizer ApS, Abacus Medicine A/S, 2care4 ApS, Orifarm A/S | 26,7 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.202.a | 2care4 ApS, Abacus Medicine A/S, Teva Denmark A/S, Macure Pharma ApS | 33,9 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.1203.a | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, +6 | 148,1 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.1205.b | Hameln Pharma ApS, Orifarm A/S, Abcur AB, Macure Pharma ApS | 44 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.213.a | Orifarm A/S, Mundipharma A/S, Abacus Medicine A/S, Boehringer Ingelheim Danmark A/S, Chiesi Pharma AB, AstraZeneca A/S | 44,4 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.703.b | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, +3 | 256,3 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.205.b | Strides Nordic ApS, Merck A/S, Aspen Pharma Ireland Limited | 13,5 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.210.a | Teva Denmark A/S, Abacus Medicine A/S, Zentiva Denmark ApS, Sun Pharmaceuticals Germany GmbH, Orifarm A/S, Nordic Prime ApS | 51,7 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.212.a | Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Abacus Medicine A/S, Chiesi Pharma AB, Paranova Danmark A/S, +1 | 33,6 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.1200.a | Macure Pharma ApS, Orifarm A/S, Aguettant Nordic ApS, Zentiva Denmark ApS, Øresund Pharma ApS, GE Healthcare A/S, +4 | 73,5 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.201.a | 2care4 ApS, LEO Pharma A/S, Abacus Medicine A/S, Viatris ApS, Octapharma Nordic AB, CSL Behring AB, +2 | 101,4 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.703.b | Ferring Lægemidler A/S, Recordati AB, Norgine Danmark A/S, Sandoz A/S, Strides Nordic ApS, Orifarm Generics A/S | 123,4 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 1.183.a | Roche Pharmaceuticals A/S | 108 mio. kr. | 14.10.2026 |
| Amgros 2027 1.182.a | Roche Pharmaceuticals A/S | 5,7 mio. kr. | 14.10.2026 |
| Amgros 2027 1.700.a | Macure Pharma ApS, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, +9 | 419,4 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 2.701.b | Vantive ApS, Fresenius Medical Care Danmark A/S, B. Braun Medical A/S | 36 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 1.706.a | Abacus Medicine A/S, GHN Pharma Nordic AB | 121 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 1.702.b | Orifarm A/S, Abacus Medicine A/S | 3,9 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 1.1171.a | Bristol-Myers Squibb Denmark. Filial Af Bristol-Myers Squibb AB. Sverige, 2care4 ApS | 300,6 mio. kr. (samlet) | 30.9.2026 |
| Amgros 2027 1.1174.a | Orifarm A/S | 12,7 mio. kr. | 30.9.2026 |
| Amgros 2026 1.1581.a | AstraZeneca A/S | 9,7 mio. kr. | 30.9.2026 |
| Amgros 2027 1.1152.a | Samsung Bioepis NL B.V. | 124 mio. kr. | 23.9.2026 |
| Amgros 2027 1.1051.b | 2care4 ApS, Orifarm A/S, Roche Pharmaceuticals A/S | 254 mio. kr. (samlet) | 23.9.2026 |
| Amgros 2027 1.1490.a | Zentiva Denmark ApS | 211 mio. kr. | 23.9.2026 |
| Amgros 2027 1.1052.b | Biocon Biologics Ireland Limited, Orion Pharma A/S, Pfizer ApS, Samsung Bioepis NL B.V., Accord Healthcare AB, Roche Pharmaceuticals A/S, +3 | 704 mio. kr. (samlet) | 23.9.2026 |
| Amgros 2027 1.1491.a | Astellas Pharma A/S, Janssen-Cilag A/S, Bayer A/S | 1,8 mia. kr. (samlet) | 22.9.2026 |
| Rammeaftale om køb af Livmarli (maralixibat) | Abacus Medicine A/S | 36 mio. kr. | 14.9.2026 |